Hantz Financial Services, Inc. Ionis Pharmaceuticals Inc Transaction History
Hantz Financial Services, Inc.
- $6.19 Billion
- Q2 2025
A detailed history of Hantz Financial Services, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 36 shares of IONS stock, worth $2,481. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36Holding current value
$2,481% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
414Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.15 Billion0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.11 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$865 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$712 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$541 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $9.79B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...